Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ENDO INTERNATIONAL PLC ENDPQ

Healthcare Drug Manufacturers - Specialty & Generic
Endo International plc has filed a voluntary petition under Chapter 11 of the U.S. Bankruptcy Code and is winding down its business. The Company has no business operations.

Recent & Breaking News (GREY:ENDPQ)

Endo Announces Appearance At The Stifel 2015 Healthcare Conference

Canada NewsWire November 10, 2015

Endo Provides Informational Frequently Asked Questions & Answers

Canada NewsWire November 9, 2015

Endo Announces It Will Enter Into Up To $250 Million Share Repurchase Program

Canada NewsWire November 6, 2015

Endo Reports Third Quarter 2015 Financial Results

Canada NewsWire November 5, 2015

FDA Approval of BELBUCA(TM) (CIII) (Buprenorphine HCl) Buccal Film for Chronic Pain Triggers Milestone Payment of $50 Million to BioDelivery Sciences from Partner Endo Pharmaceuticals

PR Newswire October 26, 2015

U.S. FDA Approves BELBUCA(TM) (buprenorphine) Buccal Film for Chronic Pain Management

Canada NewsWire October 26, 2015

Endo to Announce Third Quarter 2015 Financial Results on November 5, 2015

Canada NewsWire October 22, 2015

Endo to Announce Third Quarter 2015 Financial Results on November 5, 2015

PR Newswire October 22, 2015

Endo to Announce Third Quarter 2015 Financial Results on November 5, 2015

PR Newswire October 22, 2015

Endo Provides Update on Use of Specialty Pharmacies

PR Newswire October 21, 2015

Endo Completes Acquisition of Broad Portfolio of Branded and Generic Products from Aspen Holdings

Canada NewsWire October 1, 2015

Endo Completes Acquisition of Par Pharmaceutical and Provides Financial Guidance

PR Newswire September 28, 2015

Endo Announces Termination Of HSR Act Waiting Period In Connection With Its Proposed Acquisition Of Par Pharmaceutical

PR Newswire September 25, 2015

Endo Pharmaceuticals and BioDelivery Sciences Present New Data on Investigational Product Buprenorphine HCl Buccal Film for Chronic Pain Management

Canada NewsWire September 9, 2015

Endo Announces Appointment of Craig Paterson, M.D. as Chief Medical Officer

Canada NewsWire September 8, 2015

Endo Pharmaceuticals Announces XIAFLEX® for Dupuytren's Contracture Formal Pricing in Japan; Commercial Launch Set for September 16, 2015

Canada NewsWire August 31, 2015

Endo Announces U.S. District Court Ruling Upholding OPANA® ER Intellectual Property

Canada NewsWire August 14, 2015

Endo Announces Appearance at Canaccord Genuity 35th Annual Growth Conference

Canada NewsWire August 11, 2015

Endo Reports Second Quarter 2015 Financial Results

Canada NewsWire August 10, 2015

Endo Divests Non-Core Business Lines from Litha Healthcare Group International Business, Enhancing Focus on Specialty Pharmaceuticals

Canada NewsWire August 5, 2015